Autopsy report · NCT03707236
The Use of Teledermatology in the Treatment of Patients With Severe Acne on Isotretinoin
Cause of deathStaffing, sites or logistics
“Study was planned prior to COVID-19; after pandemic teledermatology use became prevalent making the results of this study no longer necessary/relevant”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Acne Vulgaris
- Interventions
- Teledermatology visits
- Participants
- 0
Trials that died the same way
- Improving 24-hour Blood Pressure in Obstructive Sleep Apnea
“Covid-19 Pandemic prevented this study from beginning” - Continuous Ambulatory Monitoring to Predict Elevated Risk of Infection in Children With Lymphoblastic Leukemia Undergoing Induction Chemotherapy (CAMPER-ALL)
“The study was activated at the onset of the COVID pandemic. At that time voluntary, non-therapeutic research was placed on hold. Now the technology has evolved and have elected to forego this protocol.” - Camp Based Multi-component Intervention for Families of Young Children With Type 1 Diabetes
“Study terminated due to COVID-19 pandemic” - T-MACS Decision Aid: a Randomized, Controlled Point of Care Trial
“CI no longer wishes to complete this study due to Covid-19” - The Efficacy of Denosumab in Incomplete Patients Spinal Cord Injury
“Study ended early due to COVID-19”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.